Get started
Work

A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy

Year: 2016
Type: article
DOI: 10.1016/j.ijrobp.2016.06.024
Authors: A.H. Klopp, A.R. Yeung, S. Deshmukh, K.M. Gil, L. Wenzel, S.N. Westin, K. Gifford, D.K. Gaffney, W. Small, S. Thompson, D.E. Doncals, G.H.C. Cantuaria, B. Yaremko, A. Chang, V. Kundapur, D.S. Mohan, M.L. Haas, Y.B. Kim, C.L. Ferguson, D. Watkins Bruner
Institutions: The University of Texas MD Anderson Cancer Center, University of Florida Health, University of Florida, American College of Radiology, Summa Health System, University of California, Irvine, Huntsman Cancer Institute, Loyola University Chicago, OU Health Stephenson Cancer Center, Summa Akron City Hospital, Northside Hospital, Pamela Youde Nethersole Eastern Hospital, Saskatoon Cancer Centre, Kaiser Permanente, Kaiser Permanente San Francisco Medical Center, Reading Hospital, Severance Hospital, Yonsei University Health System, Augusta University, Winship Cancer Institute
Language: English
Field: Medicine
Open Access status: bronze
Funder: NRG Oncology
OpenAlex ID: W2523912241
FWCI: 12.9
Cites:
Cited by: 49
Related to: 10